Intranasal esketamine and the dawn of precision psychiatry

Braz J Psychiatry. 2022 Mar-Abr;44(2):117-118. doi: 10.1590/1516-4446-2021-0031.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Administration, Intranasal
  • Depressive Disorder, Treatment-Resistant* / drug therapy
  • Humans
  • Ketamine* / therapeutic use
  • Psychiatry*

Substances

  • Esketamine
  • Ketamine